Remove 2001 Remove COVID-19 Remove Licensing
article thumbnail

The Proposed TRIPS Compromise Risks Setting Several Bad Precedents

Bill of Health

On March 15, 2022, STAT published text of a proposed compromise at the World Trade Organization (WTO) to temporarily relax global standards for intellectual property for COVID-19. In short, the compromise only waives a single 20-word paragraph in one article: the one dealing with exports under a non-voluntary authorization.

COVID-19 363
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – June

SQA

ANVISA published the RDC 702/2022, which repeals some requirements that were instituted to speed market approval of devices needed to treat patients during the height of the COVID-19 pandemic. The Agency recently published the first list of critical medicines for the management of the COVID-19 pandemic. 27 May 2022.

FDA 91
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

ANVISA announced major updates to its Resolution of the Collegiate Board of Directors (RDC) 185/2001. 19 Medical Rehabilitation Equipment. Medicine shortages and reduced availability of medicine represent an increasing issue across the European Union (EU) and the globe, which has been amplified by the COVID-19 pandemic.

FDA 40
article thumbnail

Health Provider News

Hall Render

million to expand training for healthcare jobs DELAWARE Abessinio Foundation makes $1 million gift to ChristianaCare’s Wilmington Campus ChristianaCare Builds Community With Habitat for Humanity Delaware to receive $4.9 to resolve alleged false claims Health care group offloads dozens of Florida facilities ahead of $1.2B Read former Gov.

article thumbnail

A Texas Mess

Drug & Device Law

So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic. 247d-6d(b)(8). distribution, sale, . . Strike three.